FIELD: medicine.
SUBSTANCE: pH of thrombocyte-poor plasma, and a diagnostic coefficient D is calculated by formula: D=const1xPPP-const2, where D is a diagnostically significant coefficient, PPP is a pH value of thrombocyte-poor plasma of an examined patient, const1=18.877, const2=139.381. If D is less than 0.25, thrombocyte hyperaggregation is stated reliably, and the value of D exceeding 0.25 makes to state reliably the absence of thrombocyte hyperaggregation signs.
EFFECT: use of the declared technique allows high-accurate and sensitive evaluation of thrombocyte hyperaggregation.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING PLATELET FUNCTIONAL ACTIVITY | 2011 |
|
RU2470303C1 |
DIAGNOSTIC TECHNIQUE FOR DISTURBED THROMBOCYTE AGGREGATION ACCOMPANYING MUCOVISCIDOSIS IN CHILDREN | 2013 |
|
RU2533287C1 |
METHOD FOR DETERMINING FUNCTIONAL STATE OF HEMOSTASIS SYSTEM | 1997 |
|
RU2138054C1 |
METHOD FOR ASSESSING HEMOSTATIC ACTIVITY | 2015 |
|
RU2601111C1 |
METHOD FOR PREDICTING INITIAL SIGNS OF HUMAN AND ANIMAL AFFECTED THROMBOCYTIC AGGREGATION | 2004 |
|
RU2279682C1 |
METHOD FOR PREDICTING VOLUME OF INDIVIDUAL BLOOD LOSSES DURING LABORS BY STUDYING HEMOSTASIS SYSTEM IN THE THIRD PREGNANCY TRIMESTER | 1999 |
|
RU2155349C1 |
METHOD OF EARLY PREDICTION OF RISK OF DEVELOPING VASCULAR INVOLVEMENTS IN ONSET OF ENDOCRINOPATHIES | 2010 |
|
RU2426123C1 |
METHOD FOR QUANTITATIVE ASSESSMENT OF THROMBOCYTE AGGREGATION ACTIVITY IN PATIENTS WITH NEW CORONAVIRAL INFECTION | 2021 |
|
RU2760095C1 |
METHOD OF DETERMINING ANTI-THROMBOTIC EFFECT OF ACETYLSALICYLIC ACID | 2007 |
|
RU2379684C2 |
METHOD OF DETERMINING RISK GROUPS FOR DEVELOPMENT OF HEMORRHAGIC COMPLICATIONS IN LABOR IN SCREENING HEMOSTASIOLOGIC EXAMINATION OF PREGNANT WOMEN IN THE FIRST TRIMESTER OF PREGNANCY | 1997 |
|
RU2126972C1 |
Authors
Dates
2011-10-20—Published
2010-04-22—Filed